D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.32% |
| 2 | Healthcare | 8.96% |
| 3 | Financials | 7.81% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
PUT
Ardmore Shipping
ASC
$669M
| $576K | ﹤0.01% |
+40,000
| New | +$532K |
|
3627
APi Group
APG
$17B
| $576K | ﹤0.01% |
45,909
-191,772
| -81% | -$2.21M |
|
3628
Crinetics Pharmaceuticals
CRNX
$8.88B
| $575K | ﹤0.01% |
31,417
-5,738
| -15% | -$101K |
|
3629
Caesarstone
CSTE
$71.6M
| $575K | ﹤0.01% |
100,632
+36,642
| +57% | +$274K |
|
3630
Bright Horizons
BFAM
$4.24B
| $574K | ﹤0.01% |
9,090
-75,841
| -89% | -$4.96M |
|
3631
Vitamin Cottage Natural Grocers
NGVC
$744M
| $573K | ﹤0.01% |
62,727
+24,279
| +63% | +$255K |
|
3632
PUT
PennyMac Financial
PFSI
$4.45B
| $572K | ﹤0.01% |
10,100
+100
| +1% | +$5.3K |
|
3633
ITT
ITT
$17.8B
| $571K | ﹤0.01% |
7,038
-4,191
| -37% | -$325K |
|
3634
Artivion
AORT
$1.31B
| $571K | ﹤0.01% |
47,083
+18,452
| +64% | +$222K |
|
3635
Evertec
EVTC
$1.94B
| $570K | ﹤0.01% |
17,617
+8,225
| +88% | +$270K |
|
3636
Alcon
ALC
$33.7B
| $570K | ﹤0.01% |
8,319
-6,481
| -44% | -$413K |
|
3637
Evolv Technologies
EVLV
$1.01B
| $570K | ﹤0.01% |
+219,976
| New | +$647K |
|
|
KRON
3638
DELISTED
Kronos Bio
KRON
| $569K | ﹤0.01% |
351,514
+43,167
| +14% | +$99.4K |
|
|
BNY
3639
PUT
Bank of New York Mellon
BNY
$106B
| $569K | ﹤0.01% |
12,500
-8,300
| -40% | -$356K |
|
|
BRY
3640
DELISTED
Berry Corp
BRY
| $569K | ﹤0.01% |
71,091
-35,860
| -34% | -$307K |
|
3641
National Fuel Gas
NFG
$7.73B
| $568K | ﹤0.01% |
+8,968
| New | +$577K |
|
3642
International Bancshares
IBOC
$4.83B
| $565K | ﹤0.01% |
12,350
-29,667
| -71% | -$1.43M |
|
3643
CRISPR Therapeutics
CRSP
$4.68B
| $565K | ﹤0.01% |
+13,900
| New | +$737K |
|
|
NEWR
3644
CALL
DELISTED
New Relic, Inc.
NEWR
| $565K | ﹤0.01% |
10,000
-10,000
| -50% | -$566K |
|
3645
Luxfer Holdings
LXFR
$456M
| $561K | ﹤0.01% |
40,862
+6,416
| +19% | +$93.6K |
|
3646
Puma Biotechnology
PBYI
$406M
| $559K | ﹤0.01% |
132,184
-406,360
| -75% | -$1.4M |
|
3647
Collegium Pharmaceutical
COLL
$1.16B
| $559K | ﹤0.01% |
24,074
+1,510
| +7% | +$30.4K |
|
3648
Ternium
TX
$9.68B
| $556K | ﹤0.01% |
18,197
-13,319
| -42% | -$398K |
|
3649
Rekor Systems
REKR
$86.9M
| $556K | ﹤0.01% |
462,937
-149,595
| -24% | -$145K |
|
3650
Atlanta Braves Holdings Series B
BATRK
$3.27B
| $555K | ﹤0.01% |
17,235
+1,915
| +13% | +$59.7K |
|
Similar funds
D.E. Shaw & Co's Q4 2022 Portfolio in Review
As of Q4 2022, D.E. Shaw & Co held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
D.E. Shaw & Co's Q4 2022 filing shows 476 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- D.E. Shaw & Co's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- D.E. Shaw & Co added most to Tesla in Q4 2022, an estimated $826M increase.
- D.E. Shaw & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- D.E. Shaw & Co fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- D.E. Shaw & Co's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- D.E. Shaw & Co opened 476 new positions and closed 783 in Q4 2022.
- D.E. Shaw & Co's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.